Results 221 to 230 of about 29,527 (256)
Some of the next articles are maybe not open access.
Anesthesia & Analgesia, 2023
Cannabidiol (CBD) is one of the most interesting constituents of cannabis, garnering significant attention in the medical community in recent years due to its proven benefit for reducing refractory seizures in pediatric patients. Recent legislative changes in the United States have made CBD readily available to the general public, with up to 14% of ...
Alexandra, Sideris, Lisa V, Doan
openaire +2 more sources
Cannabidiol (CBD) is one of the most interesting constituents of cannabis, garnering significant attention in the medical community in recent years due to its proven benefit for reducing refractory seizures in pediatric patients. Recent legislative changes in the United States have made CBD readily available to the general public, with up to 14% of ...
Alexandra, Sideris, Lisa V, Doan
openaire +2 more sources
WMJ : official publication of the State Medical Society of Wisconsin, 2023 Complementary data on the optimization of quantification of Cannabidiol and Tetrahydrocannabinol using High Performance Liquid ChromatographyTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.
Kong Choua, Thao +2 more
openaire +3 more sources
Cannabidiol (CBD) has been investigated as a pharmacological approach for treating a myriad of neurological and psychiatric disorders, the most successful of them being its use as an antiseizure drug (ASD). Indeed, CBD has reached the clinics for the treatment of certain epileptic syndromes. This chapter aims to overview the pharmacology of CBD and its
Fabrício A, Moreira +3 more
openaire +2 more sources
Fabrício A, Moreira +3 more
openaire +2 more sources
Chronic pain presents significant personal, psychological, and socioeconomic hurdles, impacting over 30% of adults worldwide and substantially contributing to disability. Unfortunately, current pharmacotherapy often proves inadequate, leaving fewer than 70% of patients with relief.
Nascimento, Glauce Crivelaro +4 more
openaire +3 more sources
Nascimento, Glauce Crivelaro +4 more
openaire +3 more sources
Cannabidiol (CBD) has been investigated for several therapeutic applications, having reached the clinics for the treatment of certain types of epilepsies. This chapter reviews the potential of CBD for the treatment of substance use disorders (SUD). We will present a brief introduction on SUD and current treatments.
Rayssa C, Briânis +2 more
openaire +2 more sources
Rayssa C, Briânis +2 more
openaire +2 more sources
Cannabidiol and cannabinol in man
Experientia, 1973Le cannabidiol administre a dose de 100 mg par os et de 30 mg par injection i.v. fut inactif dans les sujets d'etude. Le cannabinol, a dose orale de 400 mg, le fut aussi. Ces constituants du cannabis ne contribuent donc pas a l'effet pharmacologique.
openaire +2 more sources
The Polypharmacological Effects of Cannabidiol
Molecules, 2023Jorge Ivan Castillo-Arellano +2 more
exaly
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Antioxidants, 2020Elżbieta Skrzydlewska +2 more
exaly